Diagnostic screening programs help catch cancer, abnormalities or other diseases before they reach an advanced stage, saving lives and healthcare costs. Screening programs include, lung, breast, prostate, and cervical cancer, among many others.
In conjunction with prevention efforts, the introduction of screening examinations has resulted in a reduction of nearly 6 million cancer-related deaths since 1975.
Breast density is most often discussed within the context of cancer risk, but new research suggests that it also could be used as a marker of cardiometabolic health.
The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer.
NHS insitutions were already in need of imaging modalities and faculty prior to the pandemic, and now more than 600,000 people are waiting for deferred exams.
Including bone mineral density testing with patients' exams added no extra time and identified those at greater risk for fracture, Danish researchers explained recently.
Radiologists often mistake these bony lesions near the knee as more serious conditions, such as cancer, but researchers say such irregularities are typically benign.
Lead researcher Majid Fotuhi, MD, PhD, also said that completing a baseline MRI before these patients leave the hospital is “imperative" to their future treatment.
The approach was on-par with CT scan quality at detecting some of the most common findings associated with the disease, including lesions and ground-glass opacities, experts wrote in the Journal of MRI.